Curt D. Haffner
0000-0002-7480-308X
Publication & Citation Trends
Most Cited Works
Publications
36 total
Differential recognition of HIV-stimulated IL-1β and IL-18 secretion through NLR and NAIP signalling in monocyte-derived macrophages PDF
Cited by 38
OpenAlex
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors PDF
Cited by 26
OpenAlex
2,4-Diamino-8-quinazoline carboxamides as novel, potent inhibitors of the NAD hydrolyzing enzyme CD38: Exploration of the 2-position structure-activity relationships.
Cited by 11
Semantic Scholar
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors PDF
Cited by 130
OpenAlex
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38 PDF
Cited by 54
OpenAlex
Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility PDF
Cited by 43
OpenAlex
Substituted N‐{3‐[(1,1‐Dioxido‐1,2‐benzothiazol‐3‐yl)(phenyl)amino]propyl}benzamide Analogues as Potent Kv1.3 Ion Channel Blockers. Part 2.
Cited by 0
Semantic Scholar
Research Topics
Estrogen and related hormone effects
(6)
Hormonal Regulation and Hypertension
(5)
Steroid Chemistry and Biochemistry
(5)
Peptidase Inhibition and Analysis
(4)
Calcium signaling and nucleotide metabolism
(4)
Frequent Co-Authors
Affiliations
Research Triangle Park Foundation
GlaxoSmithKline (United Kingdom)
University of California, Irvine
South College
GlaxoSmithKline (United States)